Viewing Study NCT03771235


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-01-02 @ 2:11 AM
Study NCT ID: NCT03771235
Status: COMPLETED
Last Update Posted: 2024-04-29
First Post: 2018-12-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Online Mindfulness-based Tic Reduction (Phase Two)
Sponsor: Bowdoin College
Organization:

Study Overview

Official Title: Online Mindfulness-based Tic Reduction: Development and Testing (Phase Two)
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Tourette Syndrome (TS) and Persistent Tic Disorder (PTD) are chronic and potentially disabling neurobiological conditions. Although a range of pharmacological and psychosocial treatments exists, a significant number of individuals either do not respond to the current treatments or find them unacceptable. Thus, it is essential that researchers continue to develop and test novel treatment approaches.

In this randomized controlled trial the investigators will compare two different online group-based interventions for tics: a mindfulness-based program (Mindfulness-based Intervention for Tics (MBIT), and a psychoeducational and supportive therapy program (Tic Information and Coping Strategies (TICS)). The purpose of this study is to determine which intervention is more helpful for adults with a tic disorder.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: